MCK as reported
McKesson Corporation reported $403.4B of revenue over the trailing twelve months, +12% on the year before. 11 reported series are charted on this page, each one as filed.
$403.4B
Revenue, trailing twelve months · to Q4 2026 · +12% against the twelve months before
- Net Income
- $4.76B
Net Income · +45% year on year · trailing twelve months to Q4 2026
- Free Cash Flow
- $5.72B
Free Cash Flow · +3.1% year on year · trailing twelve months to Q4 2026
- Op Margin
- 1.5%
Op Margin · trailing twelve months to Q4 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $403.4B | +12% | Q4 2026 |
| Net Income | $4.76B | +45% | Q4 2026 |
| EPS | $38.41 | +49% | Q4 2026 |
| Gross Margin | 3.6% | n/a | Q4 2026 |
| Op Margin | 1.5% | n/a | Q4 2026 |
| Net Margin | 1.2% | n/a | Q4 2026 |
| ROE | −237% | n/a | Q4 2026 |
| ROA | 4.9% | n/a | Q4 2026 |
| ROIC | 450% | n/a | Q4 2026 |
| Free Cash Flow | $5.72B | +3.1% | Q4 2026 |
| P/E | 23.4 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
McKesson Corporation (MCK) - Revenue & ProfitRevenue & ProfitMcKesson Corporation (MCK)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Healthcare
Ranks #240 of 345 by Smart Score